MedPage Today on MSN
Compounded Imiquimod Shows Promise for Ocular Surface Cancers
A compounded form of imiquimod, a topical immune response modifier, showed promise as a treatment for ocular surface ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback